Association between brachial-ankle pulse wave velocity and endothelium-dependent and -independent coronary vasomotor function

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 1, 2011, Pages 34-41

  Yoshino, Tomohide ^a   Nakae, Ichiro ^a   Matsumoto, Tetsuya ^a   Mitsunami, Kenichi ^b   Horie, Minoru ^a  

^a Departments of Cardiovascular and Respiratory Medicine   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Bradykinin; Coronary blood flow; Pulse wave velocity

Indexed keywords

BRADYKININ; GLYCERYL TRINITRATE; PAPAVERINE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DIAMETER; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIABETES MELLITUS; DOPPLER FLOWMETRY; FEMALE; HEART CATHETERIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PULSE WAVE;

ADULT; AGED; ANKLE; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; BRADYKININ; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PAPAVERINE; PULSATILE FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 78650652129     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05455.x     Document Type: Article

References (52)

1. Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manag. 2005; 1: 183-98.
2. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-54.
3. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
4. Halcox JP, Schenke WH, Zalos G et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-8.
5. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur. Heart J. 2006; 27: 2588-605.
6. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41.
7. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106: 2085-90.
8. Sutton-Tyrrell K, Najjar SS, Boudreau RM et al. Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384-90.
9. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 2002; 25: 359-64.
10. Tsuchiya M, Suzuki E, Egawa K et al. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic Type 2 diabetic patients. Diabetes Care 2004; 27: 2409-15.
11. Yambe M, Tomiyama H, Hirayama Y et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens. Res. 2004; 27: 625-31.
12. Yamashina A, Tomiyama H, Arai T et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens. Res. 2003; 26: 615-22.
13. Tanaka H, Munakata M, Kawano Y et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J. Hypertens. 2009; 27: 2022-7.
14. Matsuoka O, Otsuka K, Murakami S et al. Arterial stiffness independently predicts cardiovascular events in an elderly community: Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed. Pharmacother. 2005; 59(Suppl. 1): S40-4.
15. Tomiyama H, Koji Y, Yambe M et al. Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ. J. 2005; 69: 815-22.
16. Nakae I, Takahashi M, Takaoka A et al. Coronary effects of diadenosine tetraphosphate resemble those of adenosine in anesthetized pigs: Involvement of ATP-sensitive potassium channels. J. Cardiovasc. Pharmacol. 1996; 28: 124-33.
17. Nakae I, Takahashi M, Kinoshita T, Matsumoto T, Kinoshita M. The effects of S-nitrosocaptopril on canine coronary circulation. J. Pharmacol. Exp. Ther. 1995; 274: 40-6.
18. Takaoka A, Nakae I, Takahashi M et al. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo. J. Cardiovasc. Pharmacol. 1998; 31: 231-9.
19. Minai K, Matsumoto T, Horie H et al. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: Effects of angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 2001; 37: 1565-70.
20. Kuga T, Mohri M, Egashira K et al. Bradykinin-induced vasodilation of human coronary arteries in vivo: Role of nitric oxide and angiotensin-converting enzyme. J. Am. Coll. Cardiol. 1997; 30: 108-12.
21. Wilson RF, White CW. Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986; 73: 444-51.
22. Nakae I, Matsumoto T, Horie H et al. Effects of intravenous nicorandil on coronary circulation in humans: Plasma concentration and action mechanism. J. Cardiovasc. Pharmacol. 2000; 35: 919-25.
23. Yokohama H, Matsumoto T, Horie H, Minai K, Kinoshita M. Coronary endothelium-dependent and independent vasomotor responses in patients with hypertrophic cardiomyopathy. Circ. J. 2002; 66: 30-4.
24. Matsumoto T, Takashima H, Ohira N et al. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin. J. Am. Coll. Cardiol. 2004; 44: 451-7.
25. McEniery CM, Wallace S, Mackenzie IS et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006; 48: 1-7.
26. Ichigi Y, Takano H, Umetani K et al. Increased ambulatory pulse pressure is a strong risk factor for coronary endothelial vasomotor dysfunction. J. Am. Coll. Cardiol. 2005; 45: 1461-6.
27. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989; 79: 1043-51.
28. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J. Clin. Invest. 1993; 92: 2867-71.
29. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991; 83: 2048-56.
30. Groves P, Kurz S, Just H, Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995; 92: 3424-30.
31. 9-bradykinin in humans. J. Heart Lung Transplant. 2006; 25: 187-94.
32. Hoshida S, Kato J, Nishino M et al. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 2001; 103: 630-3.
33. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1996; 27: 567-74.
34. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc. Health Risk Manag. 2007; 3: 853-76.
35. Fitch RM, Vergona R, Sullivan ME, Wang YX. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc. Res. 2001; 51: 351-8.
36. Antony I, Lerebours G, Nitenberg A. Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation 1995; 91: 1624-8.
37. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Eng. J. Med. 1990; 323: 22-7.
38. Treasure CB, Manoukian SV, Klein JL et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ. Res. 1992; 71: 776-81.
39. Kopeć G, Podolec P, Podolec J, Rubiś P, Zmudka K, Tracz W. Atherosclerosis progression affects the relationship between endothelial function and aortic stiffness. Atherosclerosis 2009; 204: 250-4.
40. Ward NC, Croft KD, Hodgson J, Rich L, Beilin LJ, Puddey IB. Brachial artery vasomotor function is inversely associated with 24-h ambulatory blood pressure. J. Hypertens. 2004; 22: 967-72.
41. Ceravolo R, Maio R, Pujia A et al. Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J. Am. Coll. Cardiol. 2003; 41: 1753-8.
42. Ryan SM, Waack BJ, Weno BL, Heistad DD. Increases in pulse pressure impair acetylcholine-induced vascular relaxation. Am. J. Physiol. 1995; 268: H359-63.
43. Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J. Am. Coll. Cardiol. 1992; 19: 809-15.
44. Treasure CB, Klein JL, Vita JA et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.
45. Drexler H, Kurz S, Jeserich M, Munzel T, Hornig B. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am. J. Cardiol. 1995; 76: E13-18.
46. Mancini GB, Henry GC, Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258-65.
47. Quinones MJ, Hernandez-Pampaloni M, Schelbert H et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann. Intern. Med. 2004; 140: 700-8.
48. Cosson E, Pham I, Valensi P, Paries J, Attali JR, Nitenberg A. Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with Type 2 diabetes and angiographically normal coronary arteries. Diabetes Care 2006; 29: 107-12.
49. Nemes A, Forster T, Lengyel C, Csanády M. Reduced aortic distensibility and coronary flow velocity reserve in diabetes mellitus patients with a negative coronary angiogram. Can. J. Cardiol. 2007; 23: 445-50.
50. Nakae I, Matsuo S, Matsumoto T, Mitsunami K, Horie M. Augmentation index and pulse wave velocity as indicators of cardiovascular stiffness. Angiology 2008; 59: 421-6.
51. Bakker SJ, IJzerman RG, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity. The missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 2000; 148: 17-21.
52. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541-7.